januari
new
coronaviru
confirm
caus
unexplain
pneumonia
group
patient
wuhan
hubei
subsequ
name
novel
coronaviru
due
increas
number
case
report
china
world
health
organ
announc
januari
emerg
new
coronaviru
pneumonia
epidem
constitut
public
health
emerg
intern
concern
februari
confirm
novel
coronaviru
diseas
case
report
china
case
countri
transmiss
capac
underestim
first
initi
studi
show
regener
number
mean
infector
could
transmit
anoth
peopl
recent
novel
studi
reveal
base
clinic
epidemiolog
data
nearli
patient
provinc
higher
sever
acut
respiratori
syndrom
coronaviru
patient
infect
determin
presenc
viru
differ
bodi
fluid
secret
excreta
patient
posit
viral
rna
detect
need
isol
mention
diagnosi
treatment
scheme
new
coronaviru
infect
pneumonia
trial
version
relief
symptom
two
success
minimum
h
sampl
interv
neg
viral
nucleic
acid
result
respiratori
specimen
isol
case
disisol
howev
persist
clearanc
viral
rna
differ
specimen
patient
remain
unclear
studi
viral
rna
detect
perform
throat
swab
stool
urin
serum
specimen
analyz
base
differ
clinic
condit
lab
result
figur
clearanc
time
viru
factor
may
influenc
retrospect
studi
approv
shanghai
public
health
clinic
center
ethic
committe
exempt
need
inform
consent
patient
januari
februari
confirm
patient
shanghai
region
admit
shanghai
public
health
clinic
center
convalesc
patient
refer
recov
nonfebril
patient
without
respiratori
symptom
two
success
minimum
h
sampl
interv
neg
revers
transcript
polymeras
chain
reaction
rtpcr
result
viral
rna
oropharyng
swab
clinic
data
lab
result
record
admiss
last
fecal
viral
rna
test
includ
sex
age
cluster
differenti
lymphocyt
count
erythrocyt
sediment
rate
esr
creactiv
protein
crp
procalcitonin
pct
glucocorticoid
treatment
group
includ
patient
ever
treat
glucocorticoid
prednisolon
dexamethason
fecesposit
fecesneg
group
classifi
base
detect
viral
rna
patient
fece
clinic
condit
lab
result
studi
subject
togeth
viral
rna
result
differ
specimen
oropharyng
swab
stool
urin
serum
day
collect
retrospect
magnet
beadmethod
nucleic
acid
extract
kit
appli
fulli
autom
nucleic
acid
extract
instrument
master
biotechnolog
china
total
rna
extract
sampl
dual
fluoresc
pcr
appli
biosystem
realtim
pcr
system
foster
citi
ca
usa
perform
accord
manufactur
instruct
statist
analys
perform
use
spss
intern
busi
machin
corpor
ibm
armonk
new
york
usa
normal
distribut
continu
variabl
summar
mean
standard
deviat
nonnorm
distribut
data
record
median
interquartil
rang
iqr
appropri
categor
variabl
express
count
percentag
categori
ttest
wilcoxon
ranksum
test
appli
test
differ
two
group
fisher
exact
test
chisquar
test
use
categor
variabl
multipl
linear
regress
appli
determin
relationship
outcom
exploratori
factor
p
consid
signific
januari
februari
patient
admit
shanghai
public
health
clinic
center
sixtysix
convalesc
patient
includ
studi
total
women
men
median
age
year
analyz
oldest
patient
year
old
youngest
year
old
differ
sex
age
without
glucocorticoid
treatment
p
p
admiss
averag
high
level
esr
mmh
highsensit
crp
mgl
pct
ngml
decreas
mmh
mgl
ngml
respect
upon
treatment
tabl
median
time
onset
symptom
first
neg
rtpcr
result
oropharyng
swab
convalesc
patient
day
improv
symptom
fever
cough
dyspnea
time
vari
greatli
patient
rang
day
rtpcr
viral
rna
perform
use
stool
urin
blood
specimen
convalesc
end
observ
period
februari
convalesc
patient
still
test
posit
viral
rna
stool
specimen
patient
stool
specimen
neg
follow
median
durat
day
twelv
patient
viral
rna
oropharyng
swab
fecal
sampl
neg
time
case
longer
durat
stool
specimen
neg
viral
rna
throat
swab
median
delay
day
viral
nucleic
acid
found
urin
four
patient
case
tabl
viral
rna
present
urin
specimen
throat
swab
neg
fourteen
serum
specimen
test
none
show
posit
result
data
shown
analysi
correl
absolut
valu
lymphocyt
crp
red
blood
cell
sediment
rate
pct
time
detoxif
fece
convalesc
perform
use
multipl
linear
regress
model
f
p
adjust
analysi
show
lymphocyt
count
may
help
predict
durat
viral
rna
detect
patient
stool
sampl
p
tabl
hospit
five
patient
receiv
glucocorticoid
treatment
durat
viral
rna
detect
throat
swab
fecal
sampl
glucocorticoid
treatment
group
longer
nonglucocorticoid
treatment
group
day
vs
day
p
day
vs
day
p
respect
analyz
differ
result
last
test
inflammatori
indic
upon
posit
result
viral
rna
fecal
sampl
statist
signific
differ
inflammatori
indic
patient
posit
neg
fecal
viral
rna
test
result
p
tabl
novel
coronaviru
firstli
identifi
respiratori
specimen
patient
viral
nucleic
acid
subsequ
detect
patient
stool
urin
gastrointestin
mucosa
recent
neonat
infect
report
indic
possibl
fecalor
vertic
transmiss
mother
child
addit
current
confirm
droplet
transmiss
direct
contact
transmiss
studi
found
viral
rna
detect
stool
patient
even
neg
result
throat
swab
continu
detect
viral
nucleic
acid
fece
suggest
viru
may
transmit
digest
tract
retransmit
aerosol
contain
virus
therefor
necessari
urgent
standard
stool
transport
process
patient
reduc
risk
transmiss
moreov
viral
rna
detect
fecal
sampl
appli
regularli
patient
even
recoveri
period
transmiss
urin
blood
may
occur
less
frequent
low
rate
posit
find
patient
glucocorticoid
wide
use
treatment
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
also
use
conjunct
drug
treat
patient
infect
howev
publish
clinic
manag
opinion
applic
glucocorticoid
recommend
unless
indic
use
glucocorticoid
may
delay
clearanc
viral
nucleic
acid
patient
avoid
viral
replic
bia
exist
studi
patient
glucocorticoid
treatment
group
sever
diseas
lower
lymphocyt
count
point
mild
patient
recommend
glucocorticoid
treatment
may
delay
viru
clearanc
random
control
doubleblind
experi
expand
sampl
size
help
clarifi
issu
cell
immun
may
play
import
role
infect
absolut
valu
lymphocyt
crp
esr
pct
measur
upon
admiss
analyz
respect
viru
clearanc
lower
absolut
valu
lymphocyt
treatment
longer
durat
viru
clearanc
relationship
fecal
viral
rna
result
inflammatori
indic
patient
analyz
statist
differ
esr
crp
pct
rehabilit
found
brief
clearanc
viral
rna
patient
stool
delay
compar
oropharyng
swab
import
detect
viral
rna
fece
convalesc
delay
clearanc
viral
rna
glucocorticoid
treatment
group
glucocorticoid
recommend
treatment
especi
mild
diseas
durat
rna
detect
may
relat
host
cell
immun
work
support
grant
firstclass
univers
firstclass
disciplin
build
project
fudan
univers
scientif
research
special
subject
novel
coronaviru
shanghai
public
health
clinic
center
none
